These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38412656)

  • 1. Studying the correlation of inflammatory cytokines to COVID-19 disease.
    Alkhattabi NA; Alharbi HM; Basabrain MA; Al-Zahrani MH; Alghamdi RA; Joharjy H; Khalifa R; Tarbiah NI
    Pathol Res Pract; 2024 Mar; 255():155215. PubMed ID: 38412656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
    Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
    Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
    Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
    Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.
    Kalinina O; Golovkin A; Zaikova E; Aquino A; Bezrukikh V; Melnik O; Vasilieva E; Karonova T; Kudryavtsev I; Shlyakhto E
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity.
    Trifonova I; Ngoc K; Nikolova M; Emilova R; Todorova Y; Gladnishka T; Christova I
    Int J Immunopathol Pharmacol; 2023; 37():3946320231163681. PubMed ID: 36927211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
    Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
    Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
    Smail SW; Babaei E; Amin K; Abdulahad WH
    Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
    Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
    Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
    Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases.
    Ghulam U; Nazim F; Farooqui N; Rizwan-Ul-Hasan S; Anwar MF; Ahmed K; Jamal A; Kayani HA; Mughal N; Hussain A; Sarria-Santamera A; Abidi SH
    PLoS One; 2022; 17(12):e0279270. PubMed ID: 36584119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19.
    Körper S; Schrezenmeier EV; Rincon-Arevalo H; Grüner B; Zickler D; Weiss M; Wiesmann T; Zacharowski K; Kalbhenn J; Bentz M; Dollinger MM; Paul G; Lepper PM; Ernst L; Wulf H; Zinn S; Appl T; Jahrsdörfer B; Rojewski M; Lotfi R; Dörner T; Jungwirth B; Seifried E; Fürst D; Schrezenmeier H
    Front Immunol; 2022; 13():1008438. PubMed ID: 36275695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
    Majeed AY; Zulkafli NES; Ad'hiah AH
    Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection.
    Kesmez Can F; Özkurt Z; Öztürk N; Sezen S
    Int J Clin Pract; 2021 Dec; 75(12):e14970. PubMed ID: 34626520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
    Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
    Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Severity Shifts the Cytokine Milieu Toward a Proinflammatory State in Egyptian Patients: A Cross-Sectional Study.
    Salem ML; Eltoukhy MM; Shalaby RE; Okasha KM; El-Shanshoury MR; Attia MA; Hantera MS; Hilal A; Eid MA
    J Interferon Cytokine Res; 2023 Jun; 43(6):257-268. PubMed ID: 37252793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profile in Egyptian children and adolescents with COVID-19 pneumonia: A multicenter study.
    Shafiek HK; El Lateef HMA; Boraey NF; Nashat M; Abd-Elrehim GAB; Abouzeid H; Hafez SFM; Shehata H; Elhewala AA; Abdel-Aziz A; Zeidan NMS; Soliman MM; Sallam MM; Nawara AM; Elgohary EA; Badr AI; Selim DM; Razek SA; Abdel Raouf BM; Elmikaty HA; Ibrahim LM; Shahin GH; Nabil RM; Ibrahim MAM; Salem HF; Moustafa AAM; Elshehawy NA; Abdel-Aziz MM; Eltrawy HH; Osman SF; Fouad RA; Afify MR; Mohamed MY; Yousif YM; Yousef AA; Arafa MA
    Pediatr Pulmonol; 2021 Dec; 56(12):3924-3933. PubMed ID: 34536070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.
    Bergantini L; d'Alessandro M; Gangi S; Bianchi F; Cameli P; Perea B; Meocci M; Fabbri G; Marrucci S; Ederbali M; Bargagli E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.